000			01940 a2200505 4500
005			20250517234930.0
264		0	_c20190826
008			201908s 0 0 eng d
022			_a1432-0843
024	7		_a10.1007/s00280-018-3680-y _2doi
040			_aNLM _beng _cNLM
100	1		_aFountzilas, Elena
245	0	0	_aA phase I clinical trial of hepatic arterial infusion of oxaliplatin and oral capecitabine, with or without intravenous bevacizumab, in patients with advanced cancer and predominant liver involvement. _h[electronic resource]
260			_bCancer chemotherapy and pharmacology _c11 2018
300			_a877-885 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Oral
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage
650	0	4	_aBevacizumab _xadministration & dosage
650	0	4	_aCapecitabine _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aHepatic Artery
650	0	4	_aHumans
650	0	4	_aInfusions, Intra-Arterial
650	0	4	_aInjections, Intravenous
650	0	4	_aLiver Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMaximum Tolerated Dose
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Invasiveness
650	0	4	_aOxaliplatin _xadministration & dosage
650	0	4	_aTreatment Outcome
700	1		_aKrishnan, Elangovan
700	1		_aJanku, Filip
700	1		_aFu, Siqing
700	1		_aKarp, Daniel D
700	1		_aNaing, Aung
700	1		_aSubbiah, Vivek
700	1		_aHong, David S
700	1		_aPiha-Paul, Sarina A
700	1		_aVining, David J
700	1		_aTsimberidou, Apostolia-Maria
773	0		_tCancer chemotherapy and pharmacology _gvol. 82 _gno. 5 _gp. 877-885
856	4	0	_uhttps://doi.org/10.1007/s00280-018-3680-y _zAvailable from publisher's website
999			_c28803009 _d28803009